Rockefeller University

A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity (2018) Beziat V, Li J, Lin JX, Ma CS, Li P, Bousfiha A, Pellier I, et al. Journal article Tuberculosis and impaired IL-23-dependent IFN-gamma immunity in humans homozygous for a common TYK2 missense variant (2018) Boisson-Dupuis S, Ramirez-Alejo N, Li Z, Patin E, Rao G, Kerner G, Lim CK, et al. Journal article The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to beta-papillomaviruses (2018) De Jong SJ, Crequer A, Matos I, Hum D, Gunasekharan V, Lorenzo L, Jabot-Hanin F, et al. Journal article Antigen targeting of Fc receptors induces strong T cell responses in vivo independent of ITAM signaling but dependent on dendritic cell subset (2018) Lehmann C, Baranska A, Heidkamp GF, Seeling M, Soulat D, Krug A, Ravetch J, et al. Conference contribution DC subset-specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo. (2017) Lehmann C, Baranska A, Heidkamp GF, Heger L, Neubert K, Luehr JJ, Hoffmann A, et al. Journal article RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury (2017) Fischer JC, Bscheider M, Eisenkolb G, Lin CC, Wintges A, Otten V, Lindemans CA, et al. Journal article Beta-6-Integrin serves as a novel tumor marker and therapeutic target for colorectal carcinoma (2017) Bengs S, Becker E, Spalinger MR, Raselli T, Kasper S, Lang S, Atrott K, et al. Conference contribution Antigen targeting of Fc-receptors induces strong T cell responses in vivo independent of ITAM signaling but dependent on dendritic cell subset (2017) Lehmann CHK, Baranska A, Heidkamp GF, Heger L, Neubert K, Lühr J, Hoffmann A, et al. Conference contribution Antigen targeting of Fc-receptors induces strong T cell responses in vivo independent of ITAM signaling but dependent on dendritic cell subsets (2017) Lehmann C, Baranska A, Heidkamp GF, Heger L, Neubert K, Lühr J, Hoffmann A, et al. Conference contribution The delivery of antigens to dendritic cells is a potent futureoption for anti-tumor therapies (2017) Lehmann C, Heger L, Neubert K, Harzer C, Amon L, Yamazaki S, Heidkamp GF, et al. Conference contribution